First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
Go back to First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial| (NASDAQ: ACON) | Delayed: 2.29 -0.04 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $ | |||
| Open | $2.33 | 52 Week Low | $ | |||
| Day High | $2.37 | P/E | N/A | |||
| Day Low | $2.26 | EPS | $ | |||
| Volume | 33,499 | |||||
| (NASDAQ: ACONW) | Delayed: 0.04 +0.01 (33.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 4,091 | |||||
